Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New technologies of internal defibrillation.

Derek J Dosdall1, Raymond E Ideker

  • 1Department of Biomedical Engineering, University of Alabama at Birmingham, 35294-0019, USA.

Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing
|September 1, 2005
PubMed
Summary

Researchers are exploring new implantable cardioverter-defibrillator (ICD) technologies to enhance treatments for atrial and ventricular fibrillation. Innovations include combined therapies and improved shock delivery to optimize defibrillation efficacy and patient comfort.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Left bundle branch area pacing preserves mechanical strain and synchrony compared to right ventricular apical pacing in an acute paired preclinical model.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2026
Same author

Left Bundle Branch Area Antitachycardia Pacing Improves Success Rate Compared to Right Ventricular Antitachycardia Pacing.

JACC. Clinical electrophysiology·2026
Same author

Effect of lead body and helix design variables on implantation success, insertion depth, and muscle torque in the left bundle branch area: Insights from an ex vivo porcine model.

Heart rhythm·2026
Same author

Left Bundle Branch Area Pacing Preserves Mechanical Strain and Synchrony Compared to Right Ventricular Apical Pacing in an Acute Paired Preclinical Model.

bioRxiv : the preprint server for biology·2025
Same author

Effect of Lead Body and Helix Design Variables on Implantation Success, Insertion Depth, and Muscle Torque in Left Bundle Branch Area: Insights from An Ex-Vivo Porcine Model.

bioRxiv : the preprint server for biology·2025
Same author

Prospective validation of SURPOINT index for creating atrial scar using Magnetic Resonance Imaging.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2025

Area of Science:

  • Biomedical Engineering
  • Cardiology
  • Medical Devices

Background:

  • Atrial and ventricular fibrillation are life-threatening arrhythmias requiring effective treatment.
  • Implantable cardioverter-defibrillators (ICDs) are crucial for managing these conditions.
  • Current ICD therapy can be improved through more efficient and patient-centered device-oriented treatments.

Purpose of the Study:

  • To review recent advancements in device-oriented treatments for atrial and ventricular fibrillation.
  • To identify innovative technologies for future implantable cardioverter-defibrillator (ICD) therapy.
  • To assess the potential of novel approaches to improve defibrillation efficacy and patient outcomes.

Main Methods:

  • Review of current scientific literature on innovative ICD technologies.

Related Experiment Videos

  • Analysis of research on combined cardiac resynchronization therapy and defibrillation.
  • Evaluation of studies on alternative defibrillation coil placements and pacing strategies.

    • Main Results:

    • Promising technologies include combined resynchronization and defibrillation, coronary venous coils, critical shock timing, and pacing during arrhythmias.
    • Atrial defibrillation with ICDs shows potential but requires methods to reduce shock-related pain for broader adoption.
    • Ongoing research focuses on enhancing the efficiency and effectiveness of ICD therapies.

    Conclusions:

    • Significant advancements are being made in device-oriented treatments for cardiac fibrillation.
    • Future ICDs may incorporate combined therapies and optimized shock delivery for improved patient care.
    • Addressing pain associated with atrial defibrillation is key to its clinical success.